These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 83354)

  • 1. Circulating antibody to myelin basic protein in relapsing-remitting multiple sclerosis? A comparative group and sequential study by radioimmunoassay.
    Biggins JA; Taylor A; Caspary EA
    J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1131-4. PubMed ID: 83354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS.
    Chou CH; Tourtellotte WW; Kibler RF
    Neurology; 1983 Jan; 33(1):24-8. PubMed ID: 6184646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to myelin basic protein in extracts of multiple sclerosis brain.
    Bernard CC; Randell VB; Horvath LB; Carnegie PR; Mackay IR
    Immunology; 1981 Jul; 43(3):447-57. PubMed ID: 6166547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans. Occurrence in sera of clinically well subjects and patients with multiple sclerosis.
    Paterson PY; Day ED; Whitacre CC; Berenberg RA; Harter DH
    J Neurol Sci; 1981 Oct; 52(1):37-51. PubMed ID: 6170739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin basic protein: a component of circulating immune complexes in multiple sclerosis.
    Dasgupta MK; Catz I; Warren KG; McPherson TA; Dossetor JB; Carnegie PR
    Can J Neurol Sci; 1983 Nov; 10(4):239-43. PubMed ID: 6197152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein? Studies employing the Shiverer mouse mutant.
    Ryberg B; Jacque C
    Acta Neurol Scand; 1986 Mar; 73(3):247-52. PubMed ID: 2424259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to myelin basic protein in multiple sclerosis.
    Herbrink P; van Lambalgen R; Sanders EA
    Neurology; 1985 Jan; 35(1):139-40. PubMed ID: 2578220
    [No Abstract]   [Full Text] [Related]  

  • 8. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.
    Carson JH; Barbarese E; Braun PE; McPherson TA
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1976-8. PubMed ID: 77020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis.
    García-Merino A; Persson MA; Ernerudh J; Díaz-Gil JJ; Olsson T
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1066-70. PubMed ID: 2428940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
    Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral responses to myelin basic protein in multiple sclerosis: a dichotomy.
    Sheremata W; Woods DD; Moscarello MA
    Adv Exp Med Biol; 1978; 100():501-11. PubMed ID: 80948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between progression of multiple sclerosis and immunogenetic as well as immunological factors].
    Cendrowski W
    Neurol Neurochir Pol; 1978; 12(2):157-60. PubMed ID: 79154
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigen-specific therapy of multiple sclerosis: the long-sought magic bullet.
    Steinman L
    Neurotherapeutics; 2007 Oct; 4(4):661-5. PubMed ID: 17920547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperreactivity to myelin basic protein in multiple sclerosis.
    Eggers AE; Tarmin L; Plank CR; Gamboa ET
    J Neurol Sci; 1981; 52(2-3):385-90. PubMed ID: 6171620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum immunoglobulin E level and search for myelin basic protein specific IgE antibodies in patients with multiple sclerosis.
    Barsoum AL; Höher PG; Kuwert EK
    Med Microbiol Immunol; 1977 Dec; 163(4):227-32. PubMed ID: 342888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serologic tests with the use of encephalitogenic protein in the diagnosis of multiple scerosis].
    Wajgt A; Torliński L; Chmielewska U
    Neurol Neurochir Pol; 1975; 9(2):185-91. PubMed ID: 50571
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin basic protein: what role in MS?
    JAMA; 1978 Jul; 240(1):15. PubMed ID: 77920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.